-transparent.png){kind=logo}
The growth hormone (GH) response to the gamma amino butyric acid type B (GABA-B) receptor agonist baclofen was measured in 10 Caucasian out-patients with DSM-III-R obsessive compulsive disorder (OCD) and 10 healthy comparison subjects. The patients also underwent a dexamethasone suppression test. The GH response was similar in both groups and there was a low rate of dexamethasone non-suppression in the patients. The data do not suggest that GABA-B receptor dysfunction is a feature of obsessive anxiety.
Related Publications
J V Lucey, and
G Butcher, and
K O'Flynn, and
A W Clare, and
G Dinan
November 1996,
Journal of psychiatry & neuroscience : JPN,
J V Lucey, and
G Butcher, and
K O'Flynn, and
A W Clare, and
G Dinan
December 1998,
Psychiatry research,
J V Lucey, and
G Butcher, and
K O'Flynn, and
A W Clare, and
G Dinan
November 1997,
Biological psychiatry,
J V Lucey, and
G Butcher, and
K O'Flynn, and
A W Clare, and
G Dinan
December 2007,
Alcohol (Fayetteville, N.Y.),
J V Lucey, and
G Butcher, and
K O'Flynn, and
A W Clare, and
G Dinan
February 1983,
The British journal of psychiatry : the journal of mental science,
J V Lucey, and
G Butcher, and
K O'Flynn, and
A W Clare, and
G Dinan
December 2009,
Revista brasileira de psiquiatria (Sao Paulo, Brazil : 1999),
J V Lucey, and
G Butcher, and
K O'Flynn, and
A W Clare, and
G Dinan
June 2010,
La Revue du praticien,
J V Lucey, and
G Butcher, and
K O'Flynn, and
A W Clare, and
G Dinan
March 1997,
Psychiatry research,
J V Lucey, and
G Butcher, and
K O'Flynn, and
A W Clare, and
G Dinan
November 1999,
The Journal of nervous and mental disease,
J V Lucey, and
G Butcher, and
K O'Flynn, and
A W Clare, and
G Dinan
May 2006,
Progress in neuro-psychopharmacology & biological psychiatry,
